Quantcast
Last updated on April 17, 2014 at 15:58 EDT

Latest Pancreatic lipase Stories

2009-03-02 13:40:40

A U.S. scientist says he's created a technique that can detect the early development of pancreatic cancer, which now has a 5 percent five-year survival rate. The optical technology developed by Northwestern University Professor Vadim Backman uses an analysis of adjacent tissue in the duodenum to detect the cancer. Scientists said the promising new technology might help raise the extremely low survival rate of pancreatic cancer patients by aiding early detection. The technique uses...

2008-06-25 12:03:12

X-Gen Pharmaceuticals Inc. announces that it has entered into an exclusive distribution agreement with Eurand Pharmaceuticals Inc. for the company's non-branded pancreatic enzyme product (PEP) Pancrelipase. In accordance with the agreement, X-Gen will represent Eurand as its authorized exclusive distribution agent for its currently marketed unbranded product. Consistent with the April 28, 2004 Federal Register Notification (as supplemented in October 2007), Eurand has both an IND and an...